Cite
Ferris MA, Smith AM, Heath SE, et al. DNMT3A Overgrowth Syndrome is associated with the development of hematopoietic malignancies in children and young adults. Blood. 2021;doi: 10.1182/blood.2021014052.
Ferris, M. A., Smith, A. M., Heath, S. E., Duncavage, E. J., Oberley, M. J., Freyer, D., Wynn, R., Douzgou, S., Maris, J. M., Reilly, A. F., Wu, M., Choo, F., Fiets, R. B., Koene, S., Spencer, D. H., Miller, C. A., Shinawi, M., & Ley, T. J. (2021). DNMT3A Overgrowth Syndrome is associated with the development of hematopoietic malignancies in children and young adults. Blood, . https://doi.org/10.1182/blood.2021014052
Ferris, Margaret A, et al. "DNMT3A Overgrowth Syndrome is associated with the development of hematopoietic malignancies in children and young adults." Blood vol. (2021). doi: https://doi.org/10.1182/blood.2021014052
Ferris MA, Smith AM, Heath SE, Duncavage EJ, Oberley MJ, Freyer D, Wynn R, Douzgou S, Maris JM, Reilly AF, Wu M, Choo F, Fiets RB, Koene S, Spencer DH, Miller CA, Shinawi M, Ley TJ. DNMT3A Overgrowth Syndrome is associated with the development of hematopoietic malignancies in children and young adults. Blood. 2021 Nov 17; doi: 10.1182/blood.2021014052. Epub 2021 Nov 17. PMID: 34788385.
Copy
Download .nbib